In EARLY TAVR, intervention improved outcomes over waiting in patients with class II or no indications for AVR consideration.

TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of innovation in research and education that will help doctors save and improve the ...

The findings highlight the importance of having an EP versed in lead management on the heart valve team, one expert says.